Skip to main content

Table 1 RECIST 1.1 and PERCIST 1.0 criteria used for therapeutic response evaluation

From: Comparison between RECIST and PERCIST criteria in therapeutic response assessment in cases of lymphoma

 RECIST 1.1PERCIST 1.0
RespondersCR Disappearance of target lesionsCMR The target lesion shows absent FDG uptake or shows SULpeak less than that of the liver
PR ≥ 30% decrease in the sum of the diameter of the target lesionsPMR ≥ 30% decrease or at least 0.8 SULpeak decrease
Non-respondersSD Increase in size < 20% or decrease size < 30%SMD Increase or decrease in the SULpeak of less than 30%
PD ≥ 20% increase in the sum of the diameter of the target lesions or newly developed lesionsPMD The target lesion shows an increase in SULpeak > 30% or at least 0.8 SULpeak increase or newly developed lesions